Abstract
Added value of mpMRI, MRI-targeted and systematic biopsy in the prediction of adverse pathologic features in contemporary prostate cancer patients undergoing radical prostatectomy
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have